Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Intangibles: 2020-2025

Historic Change in Intangibles for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $9.0 million.

  • Cellebrite DI's Change in Intangibles rose 37.50% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year increase of 27.88%. This contributed to the annual value of $2.0 million for FY2024, which is 23.97% down from last year.
  • Cellebrite DI's Change in Intangibles amounted to $9.0 million in Q3 2025, which was up 16.24% from $7.8 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Change in Intangibles registered a high of $9.0 million during Q3 2025, and its lowest value of $4.5 million during Q1 2022.
  • For the 3-year period, Cellebrite DI's Change in Intangibles averaged around $6.3 million, with its median value being $5.9 million (2023).
  • In the last 5 years, Cellebrite DI's Change in Intangibles surged by 61.56% in 2021 and then dropped by 22.27% in 2024.
  • Cellebrite DI's Change in Intangibles (Quarterly) stood at $4.8 million in 2021, then surged by 30.60% to $6.3 million in 2022, then decreased by 11.71% to $5.5 million in 2023, then increased by 4.99% to $5.8 million in 2024, then skyrocketed by 37.50% to $9.0 million in 2025.
  • Its Change in Intangibles was $9.0 million in Q3 2025, compared to $7.8 million in Q2 2025 and $6.3 million in Q1 2025.